Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Ivan Tornos is recorded as COO, Chairman, CEO and Board Member at Zimmer Biomet Holdings, Inc. (ZBH). Zimmer Biomet Holdings, Inc. reported in an 8-K filed February 25, 2025 that Ivan Tornos was appointed Chairman of the Board, effective May 29, 2025. Zimmer Biomet Holdings, Inc. reported in an 8-K filed August 22, 2023 that Ivan Tornos was appointed member of the Board of Directors, effective August 22, 2023. Zimmer Biomet Holdings, Inc. reported in an 8-K filed August 22, 2023 that Ivan Tornos was appointed President and Chief Executive Officer, effective August 22, 2023. The proxy statement of Zimmer Biomet Holdings, Inc. reports total compensation of $16,106,550 for Ivan Tornos in fiscal 2025, including a base salary of $1,281,846. Disclosed compensation is on record for 8 fiscal years. Ivan Tornos has spoken on 16 earnings calls across 1 company, most recently for Zimmer Biomet Holdings, Inc. on August 5, 2026.
“The Board, upon the recommendation of the Corporate Governance Committee, has appointed Ivan Tornos, the Company's President, Chief Executive Officer and a director, as the Chairman of the Board, effective on May 29, 2025, the day of the 2025 Annual Meeting.”
“Effective August 22, 2023, the Board appointed Ivan Tornos the Company's President and Chief Executive Officer, and elected Mr. Tornos a member of the Board of Directors to fill the vacancy resulting from Mr. Hanson's departure from the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2025-05-29–present
2023-08-22–present
2023-01-01–present
Recorded roles and call appearances connecting this person to public companies.
COO, Chairman, CEO, Board Member
2023-01-01–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Zimmer Biomet Holdings, Inc. (ZBH) | Chairman, President and CEO | $1,281,846 | $16,106,550 |
| 2024 | Zimmer Biomet Holdings, Inc. (ZBH) | President and CEO | $1,236,923 | $14,992,868 |
| 2023 | Zimmer Biomet Holdings, Inc. (ZBH) | President and CEO | $968,702 | $10,191,476 |
| 2022 | Zimmer Biomet Holdings, Inc. (ZBH) | President and CEO | $823,077 | $6,435,067 |
| 2021 | Zimmer Biomet Holdings, Inc. (ZBH) | President and CEO | $730,684 | $4,878,909 |
| 2020 | Zimmer Biomet Holdings, Inc. (ZBH) | Chief Operating Officer | $729,615 | $4,142,242 |
| 2019 | Zimmer Biomet Holdings, Inc. (ZBH) | Chief Operating Officer | $700,000 | $4,196,914 |
| 2018 | Zimmer Biomet Holdings, Inc. (ZBH) | Chief Operating Officer | $113,077 | $4,499,474 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
